- Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide. Laman, J.D., Maassen, C.B., Schellekens, M.M., Visser, L., Kap, M., de Jong, E., van Puijenbroek, M., van Stipdonk, M.J., van Meurs, M., Schwärzler, C., Günthert, U. Mult. Scler. (1998)